To the Editor:

Physical activity (PA) is a cornerstone of prevention to decrease mortality in patients with chronic cardiovascular disease, including heart failure.[@bib0001] ^,^ [@bib0002] Implantable cardiac devices offer the opportunity to monitor PA and data derived from implantable devices have been associated with short- and long-term outcomes.[@bib0003] ^,^ [@bib0004] During the severe acute respiratory syndrome coronavirus 2 pandemic, restrictions to outdoor activity were imposed by national authorities. In Italy, after the first case of coronavirus disease-2019 (COVID-19) on February 21, the so-called lockdown act was passed on March 8, 2020.[@bib0005] These rigorous measures decreased the impact of COVID-19 pandemic on the National Health System,[@bib0006] but likely resulted in changes in the ability of patients to maintain PA levels. In the current study, we examined the impact of the COVID-19 and regulatory movement restrictions on the PA of patients with an implantable cardioverter defibrillator.

Methods {#sec0001}
=======

Consecutive patients who underwent implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator implantation at ASST-Papa-Giovanni-XXIII, Bergamo, and received a LATITUDE (Boston Scientific) system were included in the analysis. The observation window was set from January 7 to April 6 2020 (91 days) and 3 evaluation periods were defined during the 13 weeks of observation: a reference period (weeks 1--4), a pre-lockdown period (weeks 5--9), and a lockdown period (weeks 10--13). Device-derived daily patient activity level was collected from the implanted devices. Differences in proportions were compared by applying χ^2^ analysis or Fisher\'s exact test, as appropriate. Statistical significance level was set at a *P* value of less than .05.

Results {#sec0002}
=======

One hundred eighty-four patients with available data during the observation period were included in the analysis (mean age 67 ± 14 years, 73% male, 44% ischemic, 38% cardiac resynchronization therapy defibrillator). Baseline and clinical characteristics are reported in Supplemental Table 1. A total of 16,303 days were analyzed (mean of 89 days per patient). The mean activity level during the observation period was 1.98 ± 1.1 h/d. The activity level was significantly lower during lockdown period (1.62 ± 1.2 h/d) than during the pre-lockdown period and reference period (2.14 ± 1.3 h/d during pre-lockdown, *P* \< .0001; 2.18 ± 1.3 h/d during reference, *P* \< .0001). No difference was found between reference and pre-lockdown period (*P* = .14). During the observation period, 3 patients were hospitalized for COVID-19 and 8 patients for cardiovascular causes at the enrolling institution (1.6% and 4.3%, respectively) [Figure 1](#fig0001){ref-type="fig"} .Fig. 1Trends of the mean day-by-day activity level of the whole study population during the observation period, from day 1 (D1, January 7, 2020) to day 91 (D91, April 6, 2020).Figure 1

The mean decrease in the activity level observed during lockdown period was of 26.1 ± 25.0% compared with the reference period. The percentage of patients who had a decrease of more than 25% (moderate to substantial) was higher during the lockdown period (range 45.9%--57.2%) compared with the pre-lockdown period (range 6.3%--18.9%). No significant differences during the reference period between female and male patients were found (2.15±1.2 h/d vs 2.19±1.3 h/d, *P* = .8411). However, the percentage decrease in activity level was greater among males (--28.2% for men vs --19.4% for women, *P* = .038).

Discussion {#sec0003}
==========

The present study demonstrates the impact of COVID-19 pandemic on activity: an average decrease in PA of 0.5 hours per day, a decrease of more than 25% compared with the activity during the 2 reference periods. The decrease was observed in every subgroup of patients and in a substantial proportion of them (up to 60% of all patients over the 12 weeks of the study). The imposed lockdown corresponded with a shift in the activity of subjects from week 8 (last week of pre-lockdown period), indicating that patients' behavioral changes anticipated the imposed restrictions, possibly a response to media coverage of the epidemic outbreak.

Patients decreased their PA irrespective of age, cardiomyopathy, or device implanted, although females showed a lesser decrease in activity level during the COVID-19 pandemic. The activity level of patients during the reference period did not predict a decrease of more than 25% of PA after the lockdown.

The substantial decrease in PA during the pandemic is noteworthy because it may expose patients to a higher risk of adverse outcomes.[@bib0005] ^,^ [@bib0007] In addition, it may lead to deconditioning and decreased exercise tolerance in a population that already has limited reserve. In this context, insufficient PA and sedentary behavior have been associated with frailty.[@bib0008] To minimize the risk for these untoward outcomes, patients should be encouraged to maintain PA levels if at all possible while adhering to the social distancing constraints imposed by the pandemic.
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Supplementary material associated with this article can be found in the online version at doi:[10.1016/j.cardfail.2020.08.005](https://doi.org/10.1016/j.cardfail.2020.08.005){#interref0001}.
